Search Page

1

Cite

Share

CD2 and the nature of protein interactions mediating cell-cell recognition.

Davis SJ, Ikemizu S, Wild MK, van der Merwe PA. Davis SJ, et al. Among authors: ikemizu s. Immunol Rev. 1998 Jun;163:217-36. doi: 10.1111/j.1600-065x.1998.tb01199.x. Immunol Rev. 1998. PMID: 9700513 Review.

Cite

Share

2

Cite

Share

Structure and interactions of the human programmed cell death 1 receptor.

Cheng X, Veverka V, Radhakrishnan A, Waters LC, Muskett FW, Morgan SH, Huo J, Yu C, Evans EJ, Leslie AJ, Griffiths M, Stubberfield C, Griffin R, Henry AJ, Jansson A, Ladbury JE, Ikemizu S, Carr MD, Davis SJ. Cheng X, et al. Among authors: ikemizu s. J Biol Chem. 2013 Apr 26;288(17):11771-85. doi: 10.1074/jbc.M112.448126. Epub 2013 Feb 15. J Biol Chem. 2013. PMID: 23417675 Free PMC article.

Cite

Share

3

Cite

Share

Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering.

Yu C, Sonnen AF, George R, Dessailly BH, Stagg LJ, Evans EJ, Orengo CA, Stuart DI, Ladbury JE, Ikemizu S, Gilbert RJ, Davis SJ. Yu C, et al. Among authors: ikemizu s. J Biol Chem. 2011 Feb 25;286(8):6685-96. doi: 10.1074/jbc.M110.182394. Epub 2010 Dec 14. J Biol Chem. 2011. PMID: 21156796 Free PMC article.

Cite

Share

4

Cite

Share

Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48.

Evans EJ, Castro MA, O'Brien R, Kearney A, Walsh H, Sparks LM, Tucknott MG, Davies EA, Carmo AM, van der Merwe PA, Stuart DI, Jones EY, Ladbury JE, Ikemizu S, Davis SJ. Evans EJ, et al. Among authors: ikemizu s. J Biol Chem. 2006 Sep 29;281(39):29309-20. doi: 10.1074/jbc.M601314200. Epub 2006 Jun 27. J Biol Chem. 2006. PMID: 16803907

Cite

Share

5

Cite

Share

A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. Lang HL, et al. Among authors: ikemizu s. Nat Immunol. 2002 Oct;3(10):940-3. doi: 10.1038/ni835. Epub 2002 Sep 3. Nat Immunol. 2002. PMID: 12244309

Cite

Share

6

Cite

Share

The nature of molecular recognition by T cells.

Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. Davis SJ, et al. Among authors: ikemizu s. Nat Immunol. 2003 Mar;4(3):217-24. doi: 10.1038/ni0303-217. Nat Immunol. 2003. PMID: 12605231 Review.

Cite

Share

7

Cite

Share

Crystal structure and functional dissection of the cytostatic cytokine oncostatin M.

Deller MC, Hudson KR, Ikemizu S, Bravo J, Jones EY, Heath JK. Deller MC, et al. Among authors: ikemizu s. Structure. 2000 Aug 15;8(8):863-74. doi: 10.1016/s0969-2126(00)00176-3. Structure. 2000. PMID: 10997905

Cite

Share

8

Cite

Share

Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1.

Davis SJ, Ikemizu S, Collins AV, Fennelly JA, Harlos K, Jones EY, Stuart DI. Davis SJ, et al. Among authors: ikemizu s. Acta Crystallogr D Biol Crystallogr. 2001 Apr;57(Pt 4):605-8. doi: 10.1107/s0907444901001895. Acta Crystallogr D Biol Crystallogr. 2001. PMID: 11264596

Cite

Share

9

Cite

Share

Structure and dimerization of a soluble form of B7-1.

Ikemizu S, Gilbert RJ, Fennelly JA, Collins AV, Harlos K, Jones EY, Stuart DI, Davis SJ. Ikemizu S, et al. Immunity. 2000 Jan;12(1):51-60. doi: 10.1016/s1074-7613(00)80158-2. Immunity. 2000. PMID: 10661405

Cite

Share

10

Cite

Share

Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.

Ikemizu S, Sparks LM, van der Merwe PA, Harlos K, Stuart DI, Jones EY, Davis SJ. Ikemizu S, et al. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4289-94. doi: 10.1073/pnas.96.8.4289. Proc Natl Acad Sci U S A. 1999. PMID: 10200255 Free PMC article.

Cite

Share